• Genentech

    Pocket Cards for Acute Ischemic Stroke Activase Therapy for Acute Ischemic Stroke Blood Pressure Control Before, During, and After Activase Therapy for Acute Ischemic Stroke Description of Activase Rapid Treatment Algorithm  

  • Recognition and Treatment of Stroke in Children

    Child Neurology Society Ad Hoc Committee on Stroke in Children E. S. Roach, M.D., Co-Chair – Dallas, TX Gabrielle deVeber, M.D. Co-Chair – Hamilton, Ontario Anthony R. Riela, M.D. – Dallas, TX Max Wiznitzer, M.D. – Cleveland, OH I. Introduction Despite growing appreciation by neurologists that cerebrovascular disorders occur more often in children than once

  • TPA Stroke Study Group Guidelines

    Administration of rt-PA to Acute Ischemic Stroke Patients Eligibility for IV treatment with rt-PA Age 18 or older. Clinical diagnosis of ischemic stroke causing a measurable neurological deficit. Time of symptom onset well established to be less than 180 minutes before treatment would begin. Patient Selection: Contraindications and Warnings Evidence of intracranial hemorrhage on pretreatment

  • Stroke Coding

    Guide of the American Academy of Neurology Algorithm for emergency treatment of blood pressure in patients with ischemic stroke. Blood pressure obtained by automatic sphygmomanometer should be correlated with a manual blood pressure cuff reading. If diastolic blood pressure > 140 mm Hg occurs on two readings 5 minutes apart, then start a continuous IV

  • Activase

    ALTEPLASE : A Recombinant Tissue Plasminogen Activator DESCRIPTION: Activase, Alteplase, is a tissue plasminogen activator produced by recombinant DNA technology. It is a sterile, purified glycoprotein of 527 amino acids. It is synthesized using the complentary DNA (cDNA) for natural human tissue-type plasminogen activator obtained from a human melanoma cell line. The manufacturing process involves

  • UC Pathways

    Program Overview In 1994, a CQI group was established to focus on management of stroke patients. Physicians and department representatives met to discuss causes of delays in patient care and opportunities for improvement. They identified rate-limiting steps in the clinical process and found opportunities for reducing costs and length of stay, increasing admissions, and achieving



Latest Posts